The STING inhibitor SN-011, which prevents spontaneous STING oligomerization and activation, prohibits type I IFN production and inflammatory gene expression induced by SAVI-associated STING mutations (Hong et al. 2021). This evidence concerns the gene STING1 and STING-associated vasculopathy with onset in infancy.